Degree of dysplasia following diagnosis of atypical squamous cells of undetermined significance is influenced by patient history and type of follow-up

Diagnostic Cytopathology

Volumn 17, Issue 1, 1997, Pages 14-19

  Ghoussoub, Rola A D ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypia; Cervical intraepithelial neoplasia; Papanicolaou smear; Premalignant

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER GRADING; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

BIAS (EPIDEMIOLOGY); BIOPSY; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030994366     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199707)17:1<14::AID-DC3>3.0.CO;2-P     Document Type: Article

References (27)

1. Melamed MR. Flehinger BJ. Non-diagnostic squamous atypia in cervico-vaginal cytology as a risk factor for early neoplasia. Acta Cytol 1976;20:108-110.
2. Patton SF Jr. Diagnostic cytopathology of the uterine cervix. Monographs in clinical cytology. Basel: S. Karger, 1978:92.
3. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:931-934.
4. Kurman RJ, Solomon D. The Bethesda System for reporting cervical/ vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer-Verlag, 1994.
5. Kurman RJ, Malkasian GD, Sedlis A, Solomon D. From Papanicolaou to Bethesda: the rationale for new cervical cytologic classification. Obstet Gynecol 1991;77:779-782.
6. Abu-Jawdeh GM, Trawinski GM, Wang HH. Histologic study of squamous atypia on Pap smears (abstract). Mod Pathol 1994;7:33A.
7. Lonky NM, Navarre GL, Saunders S, Sadeghi M, Wolde-Tsadik G. Low grade Papanicolaou smears and the Bethesda System: a prospective cytohistopathologic analysis. Obstet Gynecol 1995;85:716-720.
8. Williams ML, Rimm DL, Pedigo MA, Frable WJ. Atypical squamous cells of undetermined significance (ASCUS): correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol (in Press).
9. Sidawy MK, Tabbara SO. Reactive change and atypical squamous cells of undetermined significance in Papanicolaou smears: a cytohistologic correlation. Diagn Cytopathol 1993;9:423-429.
10. Widra EA, Dookhan, Jordan A, McCue P, Bibbo M, Dunton C. Evaluation of atypical cytologic smear. Validity of the 1991 Bethesda System. J Reprod Med 1994;39:682-684.
11. Pearlstone AC, Grigsby PW, Mutch DG. High rates of atypical cervical cytology: occurrence and clinical significance. Obstet Gynecol 1992;80: 191-195.
12. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-669.
13. Montz FJ, Bradley JM, Fowler M, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;80:385-388.
14. Rarick TL, Tchabo JG. Timing of the postpartum Papanicolaou smear. Obstet Gynecol 1994;83:761-764.
15. Saminathan T, Lahoti C, Kannan V, Kline TS. Postmenopausal squamous cell atypias: A diagnostic challenge. Diagn Cytopathol 1994;11:226-230.
16. Ridgley R, Hernandez E, Cruz C, Miyazawa K. Abnormal Papanicolaou smears after earlier smears with atypical squamous cells. J Reprod Med 1988;33:285-288.
17. Eltabbakh GH, Eltabbakh GD, Broekhuizen FF, Griner BT. Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women. Obstet Gynecol 1995;85:499-503.
18. Sherman ME, Schiffman MH, Erozan YS, Wacholder S, Kurman RJ. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. Arch Pathol Lab Med 1992;116:1155-1158.
19. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathology diagnoses with detection of high-risk human papíllomavirus types. Am J Clin Pathol 1994;102:182-187.
20. Robb JA. The "ASCUS" swamp (editorial). Diagn Cytopathol 1994;11: 319-320.
21. Young NA, Naryshkin S, Atkinson BF, et al. Interobserver variability of cervical smears with squamous cell abnormalities: a Philadelphia study. Diagn Cytopathol 1994;11:352-357.
22. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994;11:390-396.
23. Frisch LE. Inflammatory atypia: an apparent link with subsequent cervical intraepithelial neoplasia explained by cytologic underreading. Acta Cytol 1987;31:869-872.
24. Wilbur DC, Bonfiglio TA. Atypical squamous cells in cervical smears -resolving a controversy (editorial). Diagn Cytopathol 1993;9:427-429.
25. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-1869
26. ACOG. Cervical cytology: evaluation and management of abnormalities. ACOG Tech Bull 1993;183:1-8.
27. Lermon C, Miller SM, Scarborough R, Honjani P, Nolle S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991;165:658-662.